07:13 : Cynapsus Therapeutics Inc. : Cynapsus Provides Update and 2012 Outlook -
April 16, 2012 TORONTO, CANADA - Anthony Giovinazzo, President and CEO of Cynapsus Therapeutics (CTH: TSX-V), has provided shareholders with a strategy update in an open letter that is available on the company web site (www.cynapsus.ca) ...
11:43 : AGI Therapeutics sold for €6.6 million -
Aravis Therapeutics has agreed to buy AGI Therapeutics for €6.6 million, a fraction of the €85 million the Irish pharmaceuticals group was valued at when it joined the stock market in 2006.
07:55 : Cynapsus Therapeutics Inc. : Neurologist Survey Confirms Need for Improved -
December 8, 2011 Cynapsus-sponsored study suggests significant market potential for APL 130277, the Company's sublingual Apomorphine drug candidate for Parkinson's disease TORONTO, CANADA - Cynapsus Therapeutics Inc. (CTH: TSX-V) announced ...
05:40 : Argenta signs integrated services agreement with Pulmagen Therapeutics -
Mechelen, Belgium; 28 June 2011 - Galapagos NV (Euronext: GLPG) announced today that service division Argenta has signed a subcontracting agreement with Pulmagen Therapeutics Limited to perform integrated services o..